Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
Clinical trial NCT02286089 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02286089
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2021-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.